Serum Uric Acid as an Independent and Incremental Prognostic Marker in Addition to N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Acute Myocardial Infarction

Myung Hwan Bae(Kyungpook National University Hospital), Shung Chull Chae(Kyungpook National University Hospital), Yongkeun Cho(Kyungpook National University Hospital), Hun Sik Park(Kyungpook National University Hospital), Sang Hyuk Lee(Kyungpook National University Hospital), Sun Hee Park(Kyungpook National University Hospital), Jang Hoon Lee(Chungnam National University), Jae Eun Jun(Kyungpook National University Hospital), Dong Heon Yang(Kyungpook National University Hospital)
Circulation Journal
January 1, 2011
10.1253/circj.cj-10-0952
Cited by 28

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
|Journal of the American College of Cardiology|2010|278